Online citations, reference lists, and bibliographies.
← Back to Search

The Inventory For Depressive Symptomatology (IDS): Preliminary Findings

A. Rush, D. Giles, M. Schlesser, C. Fulton, J. Weissenburger, Cheryl Burns
Published 1986 · Medicine, Psychology

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
The Inventory for Depressive Symptomatology (IDS) is a new measure of depressive signs and symptoms. Both self-report and clinician-rated versions are under development. The IDS-SR (self-report) was completed by 289 patients, 285 of whom were outpatients. Unipolar major depression (n = 174), bipolar disorder (n = 44), euthymic (S/P unipolar or bipolar) depression (n = 33), and other psychiatric disorders (n = 38) were included. The IDS-SR had good internal reliability (coefficient alpha = 0.85), and significantly correlated with both the Hamilton Rating Scale for Depression (HRSD) (r = 0.67) and the Beck Depression Inventory (BDI) (r = 0.78). The clinician-rated IDS (IDS-C) was administered to 82 outpatients (75 with unipolar or bipolar disorder, 5 with other psychiatric disorders, and 2 euthymic (S/P unipolar) depressions). Coefficient alpha (0.88) suggested strong internal consistency. The IDS-C correlated highly with both the HRSD (r = 0.92) and the BDI (r = 0.61). Discriminant and factor analyses provided evidence for construct validity for both the IDS-C and IDS-SR. Both scales significantly differentiated endogenous from nonendogenous depression defined by Research Diagnostic Criteria (RDC). Factor structures for the IDS-SR revealed four factors: mood/cognition, anxiety, selected endogenous symptoms, and hyperphagia-hypersomnia. The IDS appears applicable to both inpatients and outpatients with endogenous, atypical, and nonendogenous major depression, and may have utility with dysthymics.
This paper references
10.1159/000245425
Proceedings of the Royal Society of Medicine
J. Almkvist (1912)
10.1097/00005053-190601000-00005
Archiv für Psychiatrie und Nervenkrankheiten
E. Taylor (1912)
10.1007/BF02310555
Coefficient alpha and the internal structure of tests
L. Cronbach (1951)
10.1136/jnnp.23.1.56
A RATING SCALE FOR DEPRESSION
M. Hamilton (1960)
10.1001/ARCHPSYC.1961.01710120031004
An inventory for measuring depression.
A. Beck (1961)
10.1136/bmj.1.5270.6
Treatment of Anxiety States by Antidepressant Drugs
W. Sargant (1962)
10.1192/BJP.109.461.451
THE INDEPENDENCE OF NEUROTIC DEPRESSION AND ENDOGENOUS DEPRESSION.
L. Kiloh (1965)
10.1001/ARCHPSYC.1965.01720310065008
A SELF-RATING DEPRESSION SCALE.
W. Zung (1965)
10.1016/B978-1-4832-0087-3.50014-0
CHAPTER 10 – The Minnesota Multiphasic Personality Inventory
P. Britton (1966)
10.1037/H0021000
Factors of psychopathology in interview, ward behavior, and self-report ratings of hospitalized depressives.
A. Raskin (1967)
10.1111/J.2044-8260.1967.TB00530.X
Development of a rating scale for primary depressive illness.
M. Hamilton (1967)
10.1177/003591576906201005
Measurement of feelings using visual analogue scales.
R. Aitken (1969)
SCL-90: an outpatient psychiatric rating scale--preliminary report.
L. Derogatis (1973)
10.1001/ARCHPSYC.1974.01760160005001
Endogenomorphic depression. A conceptual and terminological revision.
D. Klein (1974)
10.1001/ARCHPSYC.1978.01770310043002
A diagnostic interview: the schedule for affective disorders and schizophrenia.
J. Endicott (1978)
10.1001/ARCHPSYC.1978.01770300115013
Research diagnostic criteria: rationale and reliability.
R. Spitzer (1978)
10.1192/BJP.134.4.382
A new depression scale designed to be sensitive to change.
S. Montgomery (1979)
10.1192/BJP.138.3.194
The Carroll rating scale for depression. I. Development, reliability and validation.
B. Carroll (1981)
EEG studies of sleep in the diagnosis of depression.
M. Feinberg (1982)
Sleep EEG and dexamethasone suppression test findings in outpatients with unipolar major depressive disorders.
A. Rush (1982)
Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings.
A. Rush (1983)
10.1001/ARCHPSYC.1984.01790180039005
Phenelzine v imipramine in atypical depression. A preliminary report.
M. Liebowitz (1984)
10.1007/978-3-642-70486-4_18
The Carroll Rating Scale for Depression
M. Feinberg (1986)
10.1016/0006-3223(86)90189-7
Which endogenous depressive symptoms relate to REM latency reduction?
D. Giles (1986)



This paper is referenced by
10.1016/B978-0-12-817933-8.00029-3
The patient health questionnaire (PHQ)
M. Iglesias-González (2021)
10.2147/NDT.S283731
Implementing Measurement-Based Care for Depression: Practical Solutions for Psychiatrists and Primary Care Physicians
Ran Ha Hong (2021)
10.1016/j.cpr.2021.102000
Networks of major depressive disorder: A systematic review.
M. Malgaroli (2021)
NDT_A_283731 79..90
Zuowei Wang (2021)
10.1017/S0033291721000921
The long shadow of childhood trauma for depression in midlife: examining daily psychological stress processes as a persistent risk pathway.
Stefanie E. Mayer (2021)
10.1186/s12888-021-03156-8
The D*Phase-study: study protocol for a pragmatic two-phased, randomised controlled (non-inferiority) trial that addresses treatment non-response and compares cognitive behavioural therapy and short-term psychodynamic supportive psychotherapy for major depression
M. F. Miggiels (2021)
10.1016/j.bbi.2020.11.024
Structural brain correlates of serum and epigenetic markers of inflammation in major depressive disorder
C. Green (2021)
10.1016/j.jpsychires.2021.06.005
Efficacy of non-invasive brain stimulation in decreasing depression symptoms during the peripartum period: A systematic review.
F. Pacheco (2021)
10.1016/j.psyneuen.2021.105334
Potential associations between immune signaling genes, deactivated microglia, and oligodendrocytes and cortical gray matter loss in patients with long-term remitted Cushing’s disease
S. Bauduin (2021)
10.1016/J.BBIH.2021.100232
Blood cytokines differentiate bipolar disorder and major depressive disorder during a major depressive episode: Initial discovery and independent sample replication
E. Martinuzzi (2021)
S0033291720000823jra 2063..2073
Marie-Louise J Kullberg (2021)
10.1080/08098131.2021.1934088
Feasibility of emotion-regulating improvisational music therapy for young adult students with depressive symptoms: A process evaluation
Sonja Aalbers (2021)
10.1016/j.jad.2021.01.086
Understanding trajectories of underlying dimensions of posttraumatic psychopathology.
J. Sumner (2021)
10.1101/2021.09.15.21263562
Concurrent validity and reliability of suicide risk assessment instruments: A meta analysis of 20 instruments across 27 international cohorts
A. I. Campos (2021)
10.1007/s40473-021-00231-y
The Role of Impulsivity in Major Depression: A Systematic Review
S. Fields (2021)
10.1001/jamapsychiatry.2020.4564
Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials.
Marta M Maslej (2021)
10.1186/s12888-021-03346-4
Temporal relationships between happiness and psychiatric disorders and their symptom severity in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA)
P. Spinhoven (2021)
10.1016/j.bbih.2020.100197
Toxoplasma gondii seropositivity in patients with depressive and anxiety disorders
N. D. de Bles (2021)
10.1016/j.brs.2021.06.008
Subthreshold stimulation intensity is associated with greater clinical efficacy of intermittent theta-burst stimulation priming for Major Depressive Disorder
Jonathan Lee (2021)
10.1016/j.pnpbp.2020.110226
Activation and deactivation steps in the tryptophan breakdown pathway in major depressive disorder: A link to the monocyte inflammatory state of patients
G. Arteaga-Henríquez (2021)
10.1017/S0033291721001781
The relationship between cognitive functioning and psychopathology in patients with psychiatric disorders: a transdiagnostic network analysis.
UnYoung Chavez-Baldini (2021)
10.1159/000506879
The Hamilton Rating Scales for Depression: A Critical Review of Clinimetric Properties of Different Versions
D. Carrozzino (2020)
10.1101/2020.12.08.388942
Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature
C. Brydges (2020)
10.1192/j.eurpsy.2020.51
Psychiatric characteristics of older persons with medically unexplained symptoms: A comparison with older patients suffering from medically explained symptoms
D. Hanssen (2020)
10.4306/JKNPA.2020.59.1.61
경계성 인격장애 환자의 마음헤아리기치료 효과: 중간분석에 대한 예비보고
최 선우 (2020)
10.1001/jamapsychiatry.2019.4815
Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials.
Marta M Maslej (2020)
10.3389/fpsyt.2020.00076
The Heterogeneity of Mental Health Assessment
Jennifer J. Newson (2020)
10.1016/S2215-0366(20)30187-5
Neuromodulation for major depressive disorder: innovative measures to capture efficacy and outcomes.
Jennifer S. Rabin (2020)
10.1101/2020.08.12.20173567
DNA methylation signatures of C-reactive protein associations with structural neuroimaging measures and major depressive disorder
C. Green (2020)
10.1002/jcad.12295
A Holistic Client Functioning Profile Comparison of People With Serious Mental Illness
Michael K. Schmit (2020)
10.1177/1049731519863112
Depression Reduction Among Acupuncture Patients in an Interprofessional Study
P. Leung (2020)
10.1038/s41398-020-00980-6
Cortical thickness abnormalities in long-term remitted Cushing’s disease
S. Bauduin (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar